Effect of serum inflammatory factors in predicting co‐infection with influenza viruses and Omicron
Open Access
- 22 January 2024
- journal article
- research article
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 12 (1) , e1158
Abstract
Objectives: To identify the key differences in laboratory indicators between mono‐infection and co‐infection by influenza viruses and Omicron to facilitate timely adjustments in patient treatment strategies.Methods: Prealbumin and C‐reactive protein (CRP) levels were analyzed in 161 COVID‐19 cases infected by SARS‐CoV‐2 (wild type), 299 cases infected by Omicron, 95 cases infected by influenza virus A/B (Flu A/B) and 133 co‐infection cases infected with Flu A/B and Omicron. The receiver operating characteristic (ROC) curve and logistic regression equation were used to analyze the clinical predictive capacity of prealbumin and CRP in coinfected patients.Results: The co‐infected and wild‐type infected patients had significantly different CRP and prealbumin levels compared to mono‐infected patients with Omicron or Flu A/B (p < .001). The ROC curve results indicated that prealbumin was more efficient than CRP in identifying co‐infection from Omicron (AUC: 0.867 vs. 0.724) or Flu A/B (AUC: 0.797 vs. 0.730), and joint prediction significantly improved the diagnostic ability to discriminate co‐infection from mono‐infection (AUC: 0.934 and 0.887).Conclusion: The findings suggest that prealbumin is a valuable indicator that can warn of co‐infection and guide timely treatment decisions. Joint prediction may offer an even more effective diagnostic tool for discriminating co‐infection from mono‐infection.Keywords
All Related Versions
This publication has 11 references indexed in Scilit:
- The clinical and bioinformatics analysis for the role of antihypertension drugs on mortality among patients with hypertension hospitalized with COVID‐19Journal of Medical Virology, 2022
- SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenovirusesThe Lancet, 2022
- Omicron severity: milder but not mildThe Lancet, 2022
- Milder disease with Omicron: is it the virus or the pre-existing immunity?Nature Reviews Immunology, 2022
- Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tractNature Reviews Microbiology, 2021
- Decreased influenza activity during the COVID-19 pandemic—United States, Australia, Chile, and South Africa, 2020American Journal of Transplantation, 2020
- Serum prealbumin values predict the severity of coronavirus disease 2019 (COVID‐19)Journal of Medical Virology, 2020
- Serum prealbumin deserves more significance in the early triage of COVID-19 patientsClinical Chemistry and Laboratory Medicine (CCLM), 2020
- Clinical indications for plasma protein assays: transthyretin (prealbumin) in inflammation and malnutrition: International Federation of Clinical Chemistry and Laboratory Medicine (IFCC): IFCC Scientific Division Committee on Plasma Proteins (C-PP)Clinical Chemistry and Laboratory Medicine (CCLM), 2007
- Transthyretin-Related Familial Amyloidotic PolyneuropathyArchives of Neurology, 2005